Ibogaine is a means of alternative treatment for addiction to various substances, and it is garnering quite a lot of talk as of late. It is rapidly being recognized for its ability to diminish the impact of withdrawal when someone is attempting to ween themselves off of a substance they have become addicted to. Some even think it actually interrupts the pathways in the brain that support the addiction. Large doses have even been said to cause all cravings to subside, at least temporarily. Needless to say, a treatment with this sort of effectiveness could literally change the face of the fight against addiction.
Ibogaine itself is an active chemical found in the root of the Tabernanthe iboga, formally used only in ceremonies pertaining to the Bwiti religion in West Africa. There, its psychedelic properties have long been noted. This alone caused the drug to get a Schedule I classification in the United States. It is not addictive however, and its potential for recreational use is not particularly strong.
The overall Ibogaine success rate is something that may be open for debate since its usage in fighting addiction is still seen as relatively experimental. As with anything, more clinical studies will likely have to be conducted before a definitive scientific stance can be formed. It must be said however that even in the face of a wealth of undeniable evidence, all medicinal drugs are always subject to scrutiny, so any doubts from certain authorities on the matter should not be seen as the final word. By most accounts, Ibogaine does have powerful benefits in aiding its users to begin overcoming their addictions.
That said, Ibogaine is the sort of drug that has to be taken under explicit adherence to particular rules, and it is generally only being prescribed by therapists that can observe the patient during the treatment. As of now, only a few approved treatment centers exist. These are located throughout Europe, Mexico, and Australia. There may be some worry instilled in some when considering an apparent mortality rate having been reported of 1 in 300. That’s quite low, but any percentage of potential mortality will be seen as a red flag for some. At the time, Ibogaine is generally not being prescribed to anyone with known medical issues such as high blood pressure, risk of stroke, liver and kidney disease, and heart conditions. A history with psychological illnesses may also cause complications.
All of those considerations are fairly normal for medical treatments however. If you’ll notice, every single drug out there has a list of potential side effects or limitations to who might qualify to take it. While it is still fairly early, the existing Ibogaine success rate indicates a lot of promise. As tests continue, all of the potential complications will be further ironed out. Given the powerful nature of the drug, it’s likely that some sort of diluted version will be worked on. Regardless of anything, you can be sure that the medical world will hear quite a lot more from Ibogaine as time goes on.